Date: 2016-03-31
Type of information: Company acquisition
Acquired company: Advantar Laboratories (USA - CA)
Acquiring company: Eurofins Scientific (Luxembourg)
Amount: undisclosed
Terms: * On March 31, 2016, Eurofins Scientific, a global leader in biopharmaceutical products testing, announced that it has signed an agreement to acquire Advantar Laboratories, located in San Diego, California. Advantar’s analytical portfolio entirely complements Eurofins’ expertise, and strengthens the Group’s biopharmaceutical products testing footprint in the US. In addition, Advantar’s competencies in non-sterile manufacturing of clinical supplies and commercial products extends Eurofins’ service offering and enable further penetration into the full support
of clients’ biopharmaceutical development programs. Advantar therefore presents an excellent geographical and
operational fit for Eurofins.
Details: Advantar Laboratories is one of the leading independent GLP and cGMP contract analytical laboratories in the US west coast specializing in analytical development and formulation services for large molecule and small molecule programs ranging from pre-clinical through to late phase clinical development, as well as commercially approved drug products, medical devices and novel combination products. In 2015 Advantar has generated revenues in excess of $ 8m, with organic growth and EBITDA margin above Eurofins’ objective. The company employs 50 staff at its laboratory in San Diego, serving primarily small- to mid-size biopharmaceutical companies developing large and small molecule drug products.
Related:
